• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Phenylpyrrolidines

Recent Advances in the Study of 2-(3-Methoxyphenyl)pyrrolidine (CAS: 103861-77-4) in Chemical Biology and Pharmaceutical Research

The compound 2-(3-Methoxyphenyl)pyrrolidine (CAS: 103861-77-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. This heterocyclic compound, characterized by a pyrrolidine ring substituted with a 3-methoxyphenyl group, has been the subject of several studies exploring its pharmacological properties, synthetic pathways, and biological activities. The renewed interest in this molecule is driven by its structural versatility and its potential as a scaffold for the development of novel bioactive compounds.

Recent studies have focused on elucidating the molecular mechanisms underlying the biological effects of 2-(3-Methoxyphenyl)pyrrolidine. One notable area of investigation is its interaction with neurotransmitter systems, particularly the dopaminergic and serotonergic pathways. Preliminary in vitro and in vivo studies suggest that this compound may exhibit modulatory effects on these systems, making it a promising candidate for the treatment of neurological and psychiatric disorders. Additionally, its structural similarity to known pharmacophores has prompted researchers to explore its potential as a lead compound in drug discovery.

The synthesis of 2-(3-Methoxyphenyl)pyrrolidine has also been a focal point of recent research. Advances in synthetic methodologies have enabled more efficient and scalable production of this compound, facilitating further pharmacological evaluation. Notably, recent publications have described novel catalytic approaches that improve yield and selectivity, addressing previous challenges in its synthesis. These developments are critical for ensuring the availability of high-quality material for both research and potential clinical applications.

In addition to its neurological applications, 2-(3-Methoxyphenyl)pyrrolidine has shown promise in other therapeutic areas. Recent findings indicate potential anti-inflammatory and antimicrobial properties, broadening its scope of utility. For instance, studies have demonstrated its ability to inhibit key enzymes involved in inflammatory pathways, suggesting a possible role in managing chronic inflammatory conditions. Furthermore, its antimicrobial activity against certain bacterial strains has opened new avenues for its use in combating resistant infections.

Despite these promising developments, challenges remain in the full characterization and optimization of 2-(3-Methoxyphenyl)pyrrolidine. Current research is addressing issues related to its pharmacokinetics, toxicity profile, and specificity of action. Ongoing studies are employing advanced techniques such as molecular docking, structure-activity relationship (SAR) analysis, and high-throughput screening to refine its therapeutic potential. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate progress in this area.

In conclusion, 2-(3-Methoxyphenyl)pyrrolidine (CAS: 103861-77-4) represents a compound of significant interest in contemporary chemical biology and pharmaceutical research. Its diverse biological activities and structural adaptability make it a valuable candidate for further investigation. As research continues to uncover its mechanisms of action and optimize its properties, this compound may soon transition from the laboratory to clinical applications, offering new therapeutic options for a range of medical conditions.

• 120-20-7(2-(3,4-Dimethoxyphenyl)ethylamine)
• 52-53-9(verapamil)
• 475-83-2(Nuciferine)
• 383129-37-1(2-(3-methoxyphenyl)azepane)
• 74190-66-2(2-(4-Methoxyphenyl)pyrrolidine)
• 58-46-8(Tetrabenazine)
• 946682-03-7(1H-Azepine,2-(3-ethoxyphenyl)hexahydro-)
• 68548-75-4(2-(3-Phenoxyphenyl)pyrrolidine)
• 383127-28-4(2-(4-ethoxyphenyl)pyrrolidine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)